| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new frontier in ARDS trials: phenotyping before randomisation
|
Hendrickson, Carolyn M
|
|
2019
|
7 |
10 |
p. 830-831
|
artikel
|
| 2 |
Correction to Lancet Respir Med 2019; 7: 456–64
|
|
|
2019
|
7 |
10 |
p. e32
|
artikel
|
| 3 |
Functional effects of the microbiota in chronic respiratory disease
|
Budden, Kurtis F
|
|
2019
|
7 |
10 |
p. 907-920
|
artikel
|
| 4 |
Germline variants invited to lung cancer screening
|
Bossé, Yohan
|
|
2019
|
7 |
10 |
p. 832-833
|
artikel
|
| 5 |
Harnessing the microbiome for lung health
|
The Lancet Respiratory Medicine,
|
|
2019
|
7 |
10 |
p. 827
|
artikel
|
| 6 |
Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
|
Dai, Juncheng
|
|
2019
|
7 |
10 |
p. 881-891
|
artikel
|
| 7 |
Individualising therapy for drug-sensitive tuberculosis
|
Esmail, Hanif
|
|
2019
|
7 |
10 |
p. 834-835
|
artikel
|
| 8 |
Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis
|
Chalmers, James D
|
|
2019
|
7 |
10 |
p. 845-854
|
artikel
|
| 9 |
Lung volume reduction on the NHS
|
Burki, Talha Khan
|
|
2019
|
7 |
10 |
p. 839
|
artikel
|
| 10 |
National Asthma and COPD Audit Programme and the NHS Long Term Plan
|
Sinha, Ian P
|
|
2019
|
7 |
10 |
p. 841
|
artikel
|
| 11 |
Occupational exposures are important factors in COPD and other lung diseases
|
Furlow, Bryant
|
|
2019
|
7 |
10 |
p. 840
|
artikel
|
| 12 |
Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial
|
Constantin, Jean-Michel
|
|
2019
|
7 |
10 |
p. 870-880
|
artikel
|
| 13 |
Post-traumatic stress in the intensive care unit
|
Burki, Talha Khan
|
|
2019
|
7 |
10 |
p. 843-844
|
artikel
|
| 14 |
Raising new questions on best care for bronchiectasis
|
O'Sullivan, Brian
|
|
2019
|
7 |
10 |
p. 828-829
|
artikel
|
| 15 |
Secondary re-analysis of the FEAST trial
|
Maitland, Kathryn
|
|
2019
|
7 |
10 |
p. e29
|
artikel
|
| 16 |
Secondary re-analysis of the FEAST trial
|
Quartagno, Matteo
|
|
2019
|
7 |
10 |
p. e30
|
artikel
|
| 17 |
Secondary re-analysis of the FEAST trial – Authors' reply
|
Levin, Michael
|
|
2019
|
7 |
10 |
p. e31
|
artikel
|
| 18 |
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
|
Laska, Irena F
|
|
2019
|
7 |
10 |
p. 855-869
|
artikel
|
| 19 |
The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda
|
Naidoo, Charissa C
|
|
2019
|
7 |
10 |
p. 892-906
|
artikel
|
| 20 |
To eliminate racial and ethnic disparities in child health care, more needs to be addressed than just social determinants
|
Flores, Glenn
|
|
2019
|
7 |
10 |
p. 842-843
|
artikel
|
| 21 |
Treatment duration of checkpoint inhibitors for NSCLC
|
Remon, Jordi
|
|
2019
|
7 |
10 |
p. 835-837
|
artikel
|
| 22 |
USPTO declares CRISPR patent interference
|
Wortley, Chris
|
|
2019
|
7 |
10 |
p. 838
|
artikel
|
Tijdschrift beschrijving